Multiple Law Firms Seek Lead Plaintiffs in Securities Suit Against SES AI

Overview

• Two national plaintiff firms have publicly solicited SES investors to seek lead-plaintiff status in a putative securities class action covering purchases during the period January 29, 2025 through March 4, 2026.
• The complaints claim SES exchanged access to its Molecular Universe platform for services from vendors and used those transactions to overstate its financial performance.
• Investors who bought SES stock during the stated class period have until June 26, 2026 to move to be appointed lead plaintiff, a procedural step that will determine who steers the litigation.
• The case is at an early procedural stage: the class has not been certified, the allegations remain unproven, and the firms' press releases are attorney solicitations offering free consultations rather than evidence of wrongdoing.
• Background reporting and filings say SES disclosed operational and guidance problems in early March 2026 that triggered a sharp share decline and form the basis for investor loss claims, which could lead to motions, discovery, settlement talks, or trial if the litigation proceeds.